Psychiatry and Neurology, Neurology · Danville, PA
NPI
1841466711
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
100 N Academy Ave
Danville, PA, 17822
Phone (570) 271-6472
Groups this clinician bills Medicare through
Medicare paid, 2024
$82K
5,972 services
Medicare patients, 2024
350
Average age 71
Drug cost, 2024
$754K
4,095 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marko Reumann was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 262 times for 195 patients. In total Marko Reumann billed 5,972 services in 27 codes, and Medicare paid $82K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-30.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 262 | 195 | $11.66 | $3,054 |
| 99214 Office E&M - Established | Office | 200 | 162 | $82.19 | $16K |
| 99215 Office E&M - Established | Office | 79 | 74 | $112.55 | $8,891 |
| 95874 Musculoskeletal | Office | 51 | 34 | $22.42 | $1,143 |
| 99204 Office E&M - New | Office | 46 | 46 | $110.87 | $5,100 |
| 95874 Musculoskeletal | Facility | 41 | 26 | $12.18 | $499 |
| 64616 Musculoskeletal | Office | 34 | 22 | $120.41 | $4,094 |
| 64616 Musculoskeletal | Facility | 32 | 19 | $93.79 | $3,001 |
| 99213 Office E&M - Established | Office | 31 | 28 | $56.48 | $1,751 |
| 99203 Office E&M - New | Office | 19 | 19 | $67.18 | $1,277 |
| 99214 Office E&M - Established | Facility | 17 | 17 | $51.71 | $879 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 15 | 15 | $9.99 | $150 |
| 99443 Telephone Services | Office | 11 | 11 | $86.09 | $947 |
By year: 2022 $41K for 1,713 services; 2023 $58K for 4,261 services; 2024 $82K for 5,972 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marko Reumann prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 665 prescriptions and refills. In total Marko Reumann wrote 4,095 Medicare prescriptions that cost $754K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 665 | 1,137 | 171 | $24K |
| Primidone Generic | 367 | 658 | 79 | $8,274 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 357 | 661 | 89 | $18K |
| Carbidopa-Levodopa-Entacapone Carbidopa/Levodopa/Entacapone | 232 | 408 | 57 | $60K |
| Baclofen Generic | 171 | 219 | 39 | $3,284 |
| Clonazepam Generic | 164 | 168 | 53 | $1,723 |
| Gabapentin Generic | 161 | 268 | 44 | $2,500 |
| Zonisamide Generic | 149 | 242 | 40 | $4,433 |
| Tizanidine Hcl Generic | 112 | 174 | 35 | $1,463 |
| Rytary Carbidopa/Levodopa | 108 | 139 | 17 | $126K |
| Amantadine Amantadine Hcl | 95 | 189 | 33 | $4,621 |
| Propranolol Hcl Generic | 79 | 115 | 20 | $1,483 |
| Donepezil Hcl Generic | 76 | 119 | 13 | $685 |
| Entacapone Generic | 74 | 151 | 17 | $11K |
| Fludrocortisone Acetate Generic | 71 | 102 | 19 | $1,735 |
Brand drugs: 462 claims; generic drugs: 3,633 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Marko Reumann were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.